Our study corroborates with other studies, which have shown that 20-HETE inhibition reduces invasion in vitro, and angiogenesis and metastasis in vivo by decreasing VEGF and MMP-9 expression in human non-small cell lung cancer and MDA-MB-231 breast cancer mouse models [16,17]. This evidence concerns the gene VEGFA and breast cancer.